Holen Sie sich die Stockscreener-App
5.99
0.00%
0.00
Handel nachbörslich:
5.99
Schlusskurs vom Vortag:
$5.99
Offen:
$6.04
24-Stunden-Volumen:
49,479
Relative Volume:
1.41
Marktkapitalisierung:
$344.38M
Einnahmen:
$142.52M
Nettoeinkommen (Verlust:
$8.28M
KGV:
74.88
EPS:
0.08
Netto-Cashflow:
$-1.54M
1W Leistung:
+8.91%
1M Leistung:
+15.19%
6M Leistung:
+4.17%
1J Leistung:
+28.54%
1-Tages-Spanne:
$5.95
$6.0544
1-Wochen-Bereich:
$5.49
$6.06
52-Wochen-Spanne:
$4.58
$6.5291
Kamada Ltd Stock (KMDA) Company Profile
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-02-02 | Eingeleitet | Chardan Capital Markets | Buy |
Kamada Ltd Aktie (KMDA) Neueste Nachrichten
Kamada to Present at Stifel Healthcare Conference - TipRanks
Kamada to Present at the Stifel 2024 Healthcare Conference - GlobeNewswire
Earnings growth outpaced the 24% return delivered to Kamada (TLV:KMDA) shareholders over the last year - Simply Wall St
Blood Plasma Market to Grow by USD 15.9 Billion (2024-2028) as Innovative Solutions Address Global Blood Shortage; Report Highlights AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
Global Plasma Protein Therapeutics Market to Touch ~USD 40 Billion Mark by 2030 | DelveInsight - GlobeNewswire
What Jean-Philippe Mateta did after Daichi Kamada scored in Aston Villa 1-2 Crystal Palace, it was telling - We Are Palace
Kamada strike secures Quarter-Final spot - Holmesdale Online
Aston Villa 1-2 Crystal Palace: Daichi Kamada fires Eagles into last eight of Carabao Cupbut visitors lose - Daily Mail
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET - The Manila Times
Alvotech to Report Financial Results for the First Nine - GlobeNewswire
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19-20, 2024 - The Manila Times
Alvotech Meeting Investors and Presenting at the Jefferies - GlobeNewswire
Kamada (NASDAQ:KMDA) Shares Cross Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Kamada Ltd. Announces 2024 Annual General Meeting - TipRanks
Alpha 1 Lung Disease Market Projected to Reach $19.93 Billion by 2031 with 19.33% CAGR - WhaTech
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat
Lower Respiratory Tract Therapeutics Global Market Advancements Highlighted by Size, Insights Forecast, Tre... - WhaTech
Alpha 1 Antitrypsin Deficiency Treatment Market Size Is Booming Worldwide with Share, Size, Top Key Players - La Funcion mx
Japan's Daichi Kamada Confident in Chances of a World Cup Spot if They Beat Australia in Qualifiers - News18
Daichi Kamada says Japan can close in on World Cup place against Australia - Business Recorder
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® - The Manila Times
Kamada (NASDAQ:KMDA) Stock Crosses Below 200 Day Moving AverageShould You Sell? - MarketBeat
Equus Total Return And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Camtek Ltd. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
EastGroup Properties And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
What Oliver Glasner thinks of Daichi Kamada after slow start to life at Crystal Palace - We Are Palace
Plasma Therapy Market Advancements Highlighted by Size, Share Analysis And Forecast To 2033 - WhaTech
Lisandro Martinez is branded a 'coward' by former Premier League defender after escaping red card for 'unneces - Daily Mail
United States Genetic COPD Market Analysis By Size and Application - Third Eye News
Kamada Ltd expands plasma operations in Texas - Investing.com
Kamada Ltd expands plasma operations in Texas By Investing.com - Investing.com UK
Kamada Opens New Plasma Center in Houston - TipRanks
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston - GlobeNewswire
Kamada expands plasma collection operations in Texas - TipRanks
Kamada expands plasma collection operations in Texas with new site in Houston - Seeking Alpha
SASTRA signs MoU with Kaynes for semiconductor capacity building - Communications Today
Infra stock jumps 3% after receiving orders worth ₹ 1,003 Cr for multiple projects - Trade Brains
KEC International Boosts Market Presence with Rs 1,003 Crore New Contracts - PUNE.NEWS
India's KEC International rises on 10.03 bln rupee order wins - XM
KEC International shares surge 4% on new orders worth Rs 1,003 crore - Moneycontrol
KEC International has now won nearly 70% of the total orders it received in FY24 - CNBCTV18
Emphysema Treatment Market Innovations Investigated by Size, Share, Analysis, Trends 2024-2033 - WhaTech
'Give me my money', says Kedah winger Norde - New Straits Times
United States Alpha Antitrypsin Deficiency Treatment Market Analysis By Size and Application - Third Eye News
KDA FC Players Display ProfessionalismNafuzi - BERNAMA
Crystal Palace fans all saying the same thing about Daichi Kamada, they make one complaint - We Are Palace
Intravenous Immunoglobulin Global Market Size, Trends 2024-2033 - WhaTech
Kamada Ltd. (NASDAQ:KMDA) Shares Bought by Y.D. More Investments Ltd - MarketBeat
Kamada (NASDAQ:KMDA) Stock Price Passes Below 200-Day Moving Average of $5.50 - Defense World
Kamada (NASDAQ:KMDA) Shares Pass Below Two Hundred Day Moving Average of $5.50 - MarketBeat
Finanzdaten der Kamada Ltd-Aktie (KMDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):